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Estimating the Effect of Palliative Care Interventions and Advance Care
Planning on ICU Utilization: A Systematic Review
Abstract
OBJECTIVE: We conducted a systematic review to answer three questions: 1) Do advance care planning and
palliative care interventions lead to a reduction in ICU admissions for adult patients with life-limiting
illnesses? 2) Do these interventions reduce ICU length of stay? and 3) Is it possible to provide estimates of the
magnitude of these effects?
DATA SOURCES: We searched MEDLINE, EMBASE, Cochrane Controlled Clinical Trials, and Cumulative
Index to Nursing and Allied Health Literature databases from 1995 through March 2014.
STUDY SELECTION: We included studies that reported controlled trials (randomized and nonrandomized)
assessing the impact of advance care planning and both primary and specialty palliative care interventions on
ICU admissions and ICU length of stay for critically ill adult patients.
DATA EXTRACTION: Nine randomized controlled trials and 13 nonrandomized controlled trials were
selected from 216 references.
DATA SYNTHESIS: Nineteen of these studies were used to provide estimates of the magnitude of effect of
palliative care interventions and advance care planning on ICU admission and length of stay. Three studies
reporting on ICU admissions suggest that advance care planning interventions reduce the relative risk of ICU
admission for patients at high risk of death by 37% (SD, 23%). For trials evaluating palliative care
interventions in the ICU setting, we found a 26% (SD, 23%) relative risk reduction in length of stay with these
interventions.
CONCLUSIONS: Despite wide variation in study type and quality, patients who received advance care
planning or palliative care interventions consistently showed a pattern toward decreased ICU admissions and
reduced ICU length of stay. Although SDs are wide and study quality varied, the magnitude of the effect is
possible to estimate and provides a basis for modeling impact on healthcare costs.
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Abstract
Objective—We conducted a systematic review to answer three questions: 1) Do advance care 
planning and palliative care interventions lead to a reduction in ICU admissions for adult patients 
with life-limiting illnesses? 2) Do these interventions reduce ICU length of stay? and 3) Is it 
possible to provide estimates of the magnitude of these effects?
Data Sources—We searched MEDLINE, EMBASE, Cochrane Controlled Clinical Trials, and 
Cumulative Index to Nursing and Allied Health Literature databases from 1995 through March 
2014.
Study Selection—We included studies that reported controlled trials (randomized and 
nonrandomized) assessing the impact of advance care planning and both primary and specialty 
palliative care interventions on ICU admissions and ICU length of stay for critically ill adult 
patients.
Data Extraction—Nine randomized controlled trials and 13 nonrandomized controlled trials 
were selected from 216 references.
Data Synthesis—Nineteen of these studies were used to provide estimates of the magnitude of 
effect of palliative care interventions and advance care planning on ICU admission and length of 
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stay. Three studies reporting on ICU admissions suggest that advance care planning interventions 
reduce the relative risk of ICU admission for patients at high risk of death by 37% (SD, 23%). For 
trials evaluating palliative care interventions in the ICU setting, we found a 26% (SD, 23%) relative 
risk reduction in length of stay with these interventions.
Conclusions—Despite wide variation in study type and quality, patients who received advance 
care planning or palliative care interventions consistently showed a pattern toward decreased ICU 
admissions and reduced ICU length of stay. Although SDs are wide and study quality varied, the 
magnitude of the effect is possible to estimate and provides a basis for modeling impact on 
healthcare costs.
Keywords
advance care planning; critical care; end-of-life; intensive care unit utilization; length of stay; 
palliative care
In the United States, a significant proportion of healthcare resources are spent on care for 
critically ill patients. In 2005, critical care costs were estimated to be $82 billion, accounting 
for 13% of inpatient hospital costs (1, 2). The United States spends more hospital resources 
on critical care than any other country, as evidenced by the highest ratios of ICU bed-to-
population (20 ICU beds per 100K people) and ICU-to-hospital bed (nine ICU beds per 100 
hospital beds) in the world (2). Furthermore, a significant and rising portion of these 
expenses are for patients who die. According to a study of Medicare claims data, ICU use in 
the last 30 days of life increased 5% between 2000 and 2009 (3).
Importantly, these high-technology treatments may not be targeting outcomes that are 
consistent with patient values and preferences (4). Interventions that clarify patients’ goals 
of care and whether ICU care is consistent with these goals may reduce the intensity of end-
of-life care. For example, ICU admissions and length of stay (LOS) may be reduced by 
ensuring that patients do not receive unwanted ICU care; such interventions may incorporate 
diverse approaches including advance care planning, palliative care consultation, or ethics 
consultation (4–8). Systematic reviews (5, 9) of the impact of advance care planning or 
palliative care or ethics interventions on ICU resource utilization suggest decreases in 
resource utilization. However, none have included interventions both before and in the ICU 
setting, including primary and specialty palliative care, and none have estimated the 
magnitude of effects on ICU admission and LOS. Importantly, the primary reason for 
implementing palliative care should be to improve quality of care and patient and family 
outcomes. Nonetheless, estimates of the magnitude of these effects may be used for future 
studies modeling the potential impact of such interventions on healthcare costs (10, 11) and 
may inform future interventions and policy development.
We conducted a systematic review to answer the following questions: 1) Do advance care 
planning interventions lead to a reduction in ICU admissions for adult patients with life-
limiting illnesses when compared to usual care? 2) Do advance care planning and palliative 
care interventions reduce ICU LOS in this population when compared to usual care? and 3) 
Is it possible to provide estimates of the magnitude of these effects?
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METHODS
Data Sources
This systematic review includes published controlled trials (randomized and 
nonrandomized) reporting on the effect of advance care planning and palliative care 
interventions on ICU admissions and ICU LOS. We refer to ICU admissions and ICU LOS 
as “ICU utilization.” We excluded studies published prior to 1995 because of the impact the 
landmark Study to Understand Prognoses and Preferences for Outcomes and Risks of 
Treatments trial had on end-of-life care (12). We searched MEDLINE, EMBASE, Cochrane 
Controlled Clinical Trials, and Cumulative Index to Nursing and Allied Health Literature 
databases from 1995 through March 2014. In addition, we reviewed reference lists.
We defined relevant interventions as inclusive of advance care planning, primary palliative 
care (palliative care or communication interventions provided by nonpalliative care 
specialists such as family meetings), specialty palliative care (palliative care provided by 
palliative care specialists), and ethics consultation that include a focus on communication 
about the goals of care. We included interventions conducted in the outpatient, acute care, 
and ICU settings. We focused on adults (age ≥ 18) because interventions and outcomes in 
the neonatal ICU and PICU are likely to be very different.
Search Terms
Our search strategy used a list of terms grouped under three main subject headings: 
palliative care AND intensive care AND resource utilization (full list of search terms in e-
Table 1, Supplemental Digital Content 1, http://links.lww.com/CCM/B162). A research 
librarian at the University of Washington Health Sciences library assisted with development 
and execution of our search strategy.
Study Selection, Data Extraction, and Quality Assessment
Two researchers independently screened all titles and reviewed selected abstracts and full-
text articles (N.K., E.K.K.: practicing intensivists and researchers focusing on palliative 
care). Both researchers also independently extracted quantitative and other critical data from 
included studies. All titles were reviewed. Titles were excluded on the basis of four criteria: 
1) no specific focus on palliative or end-of-life care, 2) no relevance to ICU utilization, 3) 
editorials or narrative reviews, or 4) focus exclusively on pediatric populations. Abstracts for 
the retained titles were reviewed, and the full-text article was retrieved for any abstract 
considered potentially relevant. In the full review, we retained articles that met the following 
criteria: 1) adult patient population, 2) randomized controlled trials (RCTs) or 
nonrandomized controlled trials (non-RCTs), and 3) ICU LOS and/or ICU admission 
included as an outcome.
Data from selected articles were abstracted using a standardized instrument. A quality 
checklist was created using previously reported quality metrics (5) and recommendations 
from the Consolidated Standards for Reporting Trials group (13, 14). In addition, criteria for 
non-RCTs from the Transparent Reporting of Evaluations with Nonrandomized Designs 
were included (15). Our final quality metric checklist is a modified version of a previously 
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used checklist and included type of controls, determination of sample size, data quality, 
prespecification of outcome measures, and intervention adherence (5).
Data Synthesis and Analysis
Studies selected for inclusion were grouped by our outcomes— ICU admissions and ICU 
LOS; within these subgroups, studies were further grouped by RCTs and non-RCTs. For 
trials reporting LOS, studies were additionally categorized by intervention setting.
In order to estimate the magnitude of effect of advance care planning and palliative care 
interventions on ICU utilization, we calculated the mean relative risk reduction of ICU 
admission and ICU LOS for each study, when applicable. We then aggregated these values 
and determined the mean relative risk reduction in ICU admission and ICU LOS among all 
relevant studies. For ICU LOS, we categorized studies according to the setting in which the 
intervention took place and provided separate estimates for interventions taking place in the 
ICU, acute care, and outpatient settings.
When calculating LOS estimates, we excluded five studies for the following reasons: 1) two 
studies where intervention setting was not clear (16, 17); 2) one study not designed to study 
the effect of the intervention on resource utilization because patients were recruited if 
expected to die within a few days (18); 3) one study with a very small sample size (n = 
10/2009 eligible) (19); and 4) one study confounded by indication bias that did not report 
adjusted estimates (20). For studies that reported separate estimates for decedents (21, 22), 
we included estimates for decedents in the primary analysis because the primary mechanism 
of action for reducing ICU LOS is likely to be earlier decisions to limit life-sustaining 
therapies for patients who will die irrespective of duration of life-sustaining therapy. We 
conducted sensitivity analyses using results for survivors and the entire cohort and found 
results were similar. These data have been included in e-Table 2 (Supplemental Digital 
Content 2, http://links.lww.com/CCM/B163).
RESULTS
A total of 216 articles were identified; 44 duplicates were excluded, leaving 172 titles to be 
screened. Title review led to the exclusion of 131 articles. Of the 42 remaining abstracts and 
eight additional abstracts identified by hand-searching reference lists, full-text articles were 
retrieved for 36 studies. Of these 36 articles, 22 met our inclusion criteria (Fig. 1). All 22 
studies compared an advance care planning or palliative care intervention (as defined above) 
to usual care in adult patient populations with ICU admissions and/or ICU LOS as an 
outcome. Results of the overall methodological quality are displayed in Tables 1 and 2. A 
variety of interventions at the patient or system level were studied. Although patient 
populations varied, all were patients considered to be at high risk of death. Studies included 
in estimating the magnitude of intervention effects are listed in Tables 3 and 4. 
Heterogeneity in study interventions, study design, and study populations precluded us from 
conducting a quantitative meta-analysis.
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Trials Evaluating ICU Admissions
For all studies with ICU admissions as an outcome, the intervention was focused at the 
patient level (Tables 1 and 3).
RCTs—In a multicenter RCT, Gade et al (23) examined the effect of routine palliative care 
consultation among hospitalized patients and reported future ICU admissions as an outcome. 
In this trial, 275 patients hospitalized with a life-limiting illness received the intervention; 
237 received usual care. Patients receiving the palliative care intervention had fewer ICU 
admissions upon subsequent hospital admission (5% vs 10% in usual care; relative risk 
reduction for all patients 50%; p = 0.04).
Non-RCTs—Penrod et al (16) conducted two retrospective observational studies evaluating 
the impact of palliative care consultation on ICU admissions. In the first study, published in 
2006 and including consecutive veterans who died after hospitalization greater than 3 days, 
33% of patients receiving a palliative care consultation had an ICU admission compared to 
68% of patients receiving usual care (p < 0.001). Using multivariate probit regression to 
adjust for patient characteristics, the authors found an adjusted risk reduction of 42% (95% 
CI, −56%, −31%) in ICU admissions for patients who received a palliative care consultation. 
A subsequent, larger retrospective study consisting of 3,321 veterans hospitalized with 
advanced disease found that patients receiving palliative care consultation had an adjusted 
risk reduction of being admitted to the ICU during the same hospitalization of 44% (95% CI, 
49%, 39%; p < 0.001) (17). In this cohort, including both survivors and decedents, 33% of 
hospitalizations for patients receiving palliative care involved an ICU stay, whereas 37% of 
hospitalizations for patients in the usual care group involved an ICU stay. The mean relative 
risk reduction for all three studies combined was 37% (SD, 23%) (Table 5).
Trials Evaluating ICU LOS
Interventions in the Acute Care and Outpatient Setting: RCTs—Two randomized 
trials involved patient-centered interventions taking place outside of the ICU setting—one 
enrolled medical inpatients 80 years old and older for an advance care planning intervention 
(24) and one enrolled outpatients with a new diagnosis of life-limiting cancer for a routine 
palliative care consultation (25) (Tables 2 and 4). In the first trial, Detering et al (24) 
assessed the impact of advance care planning on end-of-life care. They randomized eligible 
patients admitted under internal medicine, cardiology medicine, or respiratory medicine in a 
large university hospital. Upon request from the authors, we were able to obtain ICU LOS 
data as this outcome was not originally reported; mean LOS was 10.9 days in the control 
arm and 5.3 days in the intervention arm (relative risk reduction for all patients 52%; no p-
value reported) (24). The second trial, Project Educate, Nurture, Advise Before Life Ends II, 
was designed to improve palliative care for patients with advanced cancer in the outpatient 
setting. This study randomized patients to a multicomponent palliative care intervention 
consisting of four weekly educational sessions: ICU LOS did not differ when compared to 
the control group receiving usual care (0.06 d for both groups; p = 1) (25).
Interventions in the ICU Setting: RCTs—Four RCTs evaluated the effect of ethics or 
palliative care consultations in the ICU on ICU LOS; for three RCTs, the intervention was 
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focused on individual patients (4, 7, 26) and one was focused at the hospital level (27). Two 
separate trials conducted by Schneiderman et al (4, 7) examined the effect of routine ethics 
consultation, enrolling patients in whom value-related treatment conflicts arose. A study 
conducted by Andereck et al (26) also examined the effect of routine ethics consultation, but 
targeted patients who were in the ICU for at least 5 days. Curtis et al (27) examined the 
effect of a multifaceted quality improvement intervention to improve palliative care skills of 
ICU clinicians, and they identified families as participants for outcome assessment from all 
adult patients who died in the ICU.
Both of the studies of routine ethics consultation in the ICU by Schneiderman et al (4, 7) 
demonstrated significant reductions in ICU LOS for decedents in the intervention group 
compared with usual care. In their single-center study, ICU LOS was 4.2 days in the 
intervention group versus 13.2 days with usual care (relative risk reduction of 68%; p = 
0.03) (7). The impact on LOS among decedents was lower in the larger, seven-center trial, 
although still statistically significant (6.4 d for intervention vs 7.9 d in usual care; relative 
risk reduction of 18%; p = 0.03) (4). Neither trial found a difference in ICU LOS for patients 
who survived to hospital discharge.
By contrast, the two RCTs assessing ICU LOS as an outcome found negative results. 
Andereck et al (26) failed to find any difference in ICU LOS attributable to an ethics 
consultation intervention; both intervention and control patients had the same LOS (11 d; p 
= 0.91). Similarly, the quality improvement intervention by Curtis et al (27) targeted at 
hospitals and clinicians to integrate palliative care in the ICU did not result in a significant 
decrease in LOS (5 vs 6 d, intervention vs control, respectively; p = 0.07).
Interventions in the ICU Setting: Non-RCTs—Ten non-RCTs reported ICU LOS as a 
study outcome. For seven, the interventions targeted patients and three targeted the ICU. 
Eight studies reported a decrease in ICU LOS associated with a palliative care intervention. 
Ahrens et al (28) evaluated the impact of a communication team consisting of a physician 
and clinical nurse specialist with predefined roles aimed at addressing barriers to 
communication; patients in the intervention group had shorter LOS compared with the 
control group (6.1 d vs 9.5 d; relative risk reduction for all patients 36%; p < 0.01). The 
study of palliative care consults for patients with global cerebral ischemia after 
cardiopulmonary resuscitation using historical controls by Campbell and Guzman (29) 
found a decrease in LOS (3.7 d vs 7.1 d; relative risk reduction for all patients 48%; p < 
0.01). In this same study, however, patients with multisystem organ failure did not spend a 
significantly longer time in the ICU when compared with historical controls receiving usual 
care (p = 0.74). The following year, Campbell and Guzman (30) published another study 
using historical controls and found that proactive palliative care consultation led to a 
significant reduction in ICU LOS for patients with advanced dementia (3.5 d vs 6.8 d; 
relative risk reduction for all patients 49%; p < 0.01). Proactive case finding involved 
screening the medical ICU (MICU) census daily for any patient meeting study criteria. 
Using nonrandomized controls, Dowdy et al (21) reported a 6-day reduction in LOS when 
the ethics service intervened proactively after patients received more than 96 hours of 
continuous mechanical ventilation (relative risk reduction for decedents 30%; no p-value 
reported).
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Four of the eight studies that found a reduction in ICU LOS were pre-post in design. Of 
these, two focused on ICU system change. In a single-center study, Curtis et al (31) 
evaluated the impact of a quality improvement intervention targeted to ICU personnel and 
designed to integrate palliative care into the ICU; median ICU LOS was shorter in the 
postimplementation period (3 d vs 4 d; relative risk reduction for all patients 19%; p = 0.01). 
As described above, this difference was not observed in the follow-up multicenter cluster 
RCT (27). Mosenthal et al (32) evaluated the impact of integrating, into standard care in a 
trauma ICU, a structured palliative care intervention consisting of assessment of patient 
prognosis and preferences, an interdisciplinary family meeting, and family bereavement 
support. Among decedents, median LOS decreased from 3 days to 1 day in the 
postimplementation period for relative risk reduction of 19%. Results of hypothesis testing 
were not reported.
Among the patient-focused interventions, Lilly et al (33) evaluated the impact of a 
multidisciplinary family meeting held within 72 hours of admission to the MICU; they 
found a reduction in median LOS in the postimplementation phase when compared with the 
baseline period (3 d vs 4 d; relative risk reduction for all patients 25%; no p-value reported). 
Similarly, Norton et al (22) evaluated the impact of proactive palliative care consultation for 
patients admitted to the MICU and identified to be at high risk of death. This study, using a 
pre/post nonequivalent control group design, found a significant reduction in ICU LOS when 
compared to usual care (9 d vs 16 d; relative risk reduction for decedents 60%; p < 0.01).
Lastly, two of these studies did not identify a difference in ICU LOS with the intervention. 
Shelton et al (34) evaluated the effect of adding a full-time family support coordinator to a 
surgical ICU team in a pre-post study design; no differences in LOS were observed in the 
pre versus postimplementation period (11.8 d vs 11.4 d, respectively, p = 0.89). In a patient-
targeted intervention, Daly et al (35) enrolled patients from five different ICUs and evaluated 
the effectiveness of an intensive communication strategy in a pre-post design; there were no 
significant differences in ICU LOS (13.4 d vs 14.4 d, pre vs post, respectively; p = 0.16).
Summary Statistics for Reduction in ICU Admissions and ICU LOS
The estimates for mean relative risk reduction by intervention type are displayed in Table 5. 
The mean relative risk reduction for ICU admissions associated with advance care planning 
and palliative care interventions was 37% (SD, 23%). The mean relative risk reduction for 
ICU LOS associated with all palliative care interventions in the ICU setting was 26% (SD, 
23%). When restricting to palliative care interventions in the ICU setting that were directly 
targeted at the level of individual patients, the mean relative risk reduction was 33% (SD, 
23%).
DISCUSSION
Our systematic review included 22 studies—nine RCTs and 13 non-RCTs. Interventions 
were diverse, populations were heterogeneous, and study designs varied. Variability in these 
dimensions limited our ability to conduct a quantitative meta-analysis. Despite this, two 
important trends emerged that warrant further investigation: 1) studies targeting ICU 
admissions suggest that advance care planning and palliative care interventions reduce the 
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number of ICU admissions for patients at high risk of death; and 2) the majority of studies 
demonstrated a reduced ICU LOS with advance care planning or palliative care 
interventions.
For the three studies reporting on ICU admissions, the mean relative risk reduction in 
percentage of admissions seen with palliative care consultations was 37% (SD, 23%). Two of 
these studies were retrospective studies that used instrumental variable (16) and propensity 
score matching (17) techniques to control for potential confounding, and one study was an 
RCT (23). All interventions were targeted directly at patients rather than at the system level. 
These studies suggest the value of targeting the intervention to appropriate patients and that 
the effect of an intervention will vary widely based on the “risk” of the target population.
Although the trend for studies reporting ICU LOS favored decreased utilization, significant 
variability was present. Among the 16 studies used to estimate the magnitude of effect, 11 
reported a decrease in LOS and five demonstrated no change. There are several possible 
reasons for this observed variability. First, baseline characteristics of selected patients may 
have influenced results. For example, in the trial by Andereck et al (26), any adult patient in 
the ICU for at least 5 days was included; the lack of restriction on baseline comorbidities or 
palliative care needs and the fact that patients were already in the ICU for 5 days at 
enrollment may have made it more difficult for palliative care interventions to affect LOS. 
Second, intervention location differed among trials (outpatient, acute care, ICU). For 
example, in the RCT conducted by Bakitas et al (25), the intervention took place in the 
outpatient setting, potentially reducing the impact on ICU LOS. Third, intervention targets 
varied between studies (patient vs system). For example, two of the trials reporting no 
difference in LOS involved system-level interventions with patient-level outcomes, which 
could potentially attenuate the effect seen on ICU LOS (27, 34). For these reasons, we 
separated interventions by setting and level of the intervention target.
Even among trials that reported a decrease in LOS, the magnitude of effect varied 
significantly. One explanation for this may be the alignment of the intervention target and 
unit of analysis for outcomes. Although some heterogeneity is present, in general, patient-
targeted interventions were more successful in reducing utilization than system-level 
interventions. Perhaps attenuation of measurable impact is more likely when the intervention 
takes place at a different level than the assessed outcome. Additionally, the degree of impact 
of advance care planning and palliative care consultation on ICU utilization is dependent on 
selecting the appropriate patients and tailoring of care to the individual patient.
The observed variability might also be explained by differences associated with studying 
decedent versus surviving subjects. Researchers should separate decedents and survivors for 
analyses as implications for reduced LOS are very different for survivors versus decedents 
(36).
Our review highlights limitations in existing data that make it difficult to provide precise 
estimates of the effects that advance care planning and palliative care interventions have on 
reducing ICU admissions and ICU LOS. Future studies are needed in order to address these 
limitations and provide more accurate assessments of the magnitude of effect on resource 
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utilization. For example, it was difficult to assess whether the strength (“dose”) of 
interventions was sufficient to be effective and whether residual confounding or selection 
bias influenced findings. Additionally, while our study questions focused on ICU utilization, 
consistently reporting hospital LOS along with ICU LOS is important when assessing the 
true economic effect of a reduced ICU LOS as the marginal benefit between an ICU day 
saved versus a hospital day saved is a debated topic that requires further evaluation (10, 11, 
37). Lastly, although data from RCTs are generally considered more robust, observational 
data and non-RCT study designs may be more pragmatic in this patient population. Methods 
to reduce bias such as multivariate regression techniques, propensity score matching, and 
instrumental variable adjustment should be routinely used in non-RCTs. However, rigorous 
randomized trials are still needed.
Our systematic review also has several limitations. First, we acknowledge that a major 
limitation of the estimates provided for reduced ICU admissions and LOS is the wide 
variability. However, this is a reflection of the current literature, and future studies are 
needed to increase the precision of these estimates. Second, our review may be limited by 
publication bias as we did not attempt to identify unpublished studies and articles. Third, our 
search strategy may have missed pertinent studies. However, because we identified the same 
list of included publications in multiple databases, reference lists, and other systematic 
reviews (5, 9, 38), we have considerable confidence in the accuracy and completeness of 
review. Lastly, our search strategy excluded studies that focused on early palliative care 
interventions with an outcome of hospital admissions if ICU admission was not a reported 
outcome. We recognize that not including these studies may lead to an underestimation of 
the quality of evidence for early palliative care interventions.
Despite the limitations of the existing literature, it is possible to provide estimates of the 
magnitude of effect of advance care planning and palliative care interventions on ICU 
admission and ICU LOS for patients with life-limiting illness. Although the target 
population and the interventions themselves are heterogeneous, assessment of the effect of 
palliative care interventions across different settings and times provides greater external 
validity for these estimates (39). Indeed, these compound estimates are more reliable for 
future studies of the potential effects of palliative care interventions on critically ill patients, 
regardless of the underlying disease or condition, than using estimates from one RCT 
involving a specific population. The primary rationale for advance care planning or palliative 
care interventions is to improve quality of care, ensure patients receive the care they would 
choose if fully informed, and improve patient and family outcomes. However, understanding 
and quantifying the potential for reduction in unwanted intensive care at the end of life may 
have important clinical and economic implications for how we approach end-of-life care in 
the hospital and ICU settings. These interventions aim to relieve suffering and improve 
overall quality of life for patients with advanced life-limiting illnesses and their families, yet 
may be difficult to implement in an effective or cost-effective way. Demonstrating that these 
interventions have the potential to lead to significant cost savings may guide decisions on 
resource allocation for end-of-life care in the ICU. In an era focused on cost containment 
and transition from fee-for-service to the Accountable Care Organization environment, 
understanding the true effect of advance care planning and palliative care interventions on 
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ICU resource utilization will be increasingly important, and this systematic review provides 
a useful step in this direction.
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Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Flow diagram of article inclusion. CCT = Controlled Clinical Trials, CINAHL = Cumulative 
Index to Nursing and Allied Health Literature.
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Table 4
Trials Reporting on ICU Length of Stay Included in Estimates of Effect by Intervention Target
Author (Reference)
Difference in ICU Length of
Stay for Intervention
Minus Control
Percent Relative Risk Reduction
for Intervention Group
Compared With Control
Decedent
Analysis
Intervention target: Patients in tde acute care setting
  Detering et al (24)a Mean: −5.7 d 52 No
Median: −8 d
Intervention target: Patients in the outpatient setting
  Bakitas et al (25) No change 0 No
Intervention target: Patients and/or providers in the ICU
  Schneiderman et al (7) −9 d 68 Yes
  Schneiderman et al (4) −1.4 d 18 Yes
  Ahrens et al (28) −3.4 d 36 No
  Campbell and Guzman et al (29) Global cerebral ischemia: −3.4 d 48 No
Multisystem organ failure: No change
  Campbell and Guzman et al (30) −3.3 d 49 No
  Dowdy et al (21) Survivors: −6 d Survivors: 28 Yes
Decedents: −13 d Decedents: 30
  Lilly et al (33) −1 d 25 (median) No
  Norton et al (22) Overall: −7.3 d Entire cohort: 45; decedents: 60 Yes
Medical ICU decedents: −8.4 d
  Andereck et al (26) No change 0 Yes
  Daly et al (35) No change 0 No
Intervention target: System ± patient in ICU setting
  Curtis et al (31) Mean: −1.4 d 19 mean Yes
Median: −0.8 d 21 median
  Mosenthal et al (32) Mean: −1.5 d 19 mean; 67 median Yes
Median: −2 d
  Curtis et al (27) No change 0 Yes
  Shelton et al (34) No change 0 No
For additional information, see e-Table 3 (Supplemental Digital Content 3, http://links.lww.com/CCM/B164).
a
Data provided by authors.
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Table 5
Estimates of Intervention Effect Size
Category
Percent
Relative Risk
Reductiona
Trials reporting on ICU admissions (n = 3)
  Mean (SD) 37 (23)
  Median (IQR) 50 (11, 51)
Trials reporting on ICU length of stay
  Intervention in acute care setting (n = 1) 52
  Intervention in outpatient setting (n = 1) No change
  Intervention in ICU settingb (n = 14)
    Mean (SD) 26 (23)
    Median (IQR) 22 (48, 0)
  Intervention in ICU setting restricted to patient/provider targets (n = 10)
    Mean (SD) 33 (23)
    Median (IQR) 33 (49, 18)
IQR = interquartile range.
a
Mean relative risk reduction value used from each trial except for Lilly trial (33), which only reported a median reduction in length of stay.
b
For trials with separate values for survivors and decedents, we selected the relative risk reduction for decedents.
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